ABSTRACT Purpose: To compare the efficacy of intravitreal ranibizumab and bevacizumab treatment for type 1 retinopathy of prematurity (ROP). Methods: 36 eyes of 20 patients with type 1 ROP who receive
Purpose: Low gestational birth weight is associated with increased incidence of Retinopathy of Prematurity (ROP). In recent years, intravitreal injection of anti-vascular endothelial growth factor (VE
